FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Food regulator FSSAI on Friday said it has suspended the licence of Punjab-based Rehaan Healthcare after it found serious violations of rules at the company’s health supplements and nutraceuticals manufacturing unit.

Rehaan Healthcare, which manufactures digestive syrup, multi-vitamin syrup and other syrup-based food products, has been asked to stop production till it corrects all deficiencies and the rectification gets verified by the competent authority.

FSSAI, during the inspection, found the manufacturing unit in unhygienic condition with poor infrastructure and other basic facilities, posing a serious health risk.

The regulator warned that legal action will be initiated if the Mohali-based company violates this order.

In a social media post on Friday, the Food Safety and Standards Authority of India (FSSAI) informed, “The license of Rehaan Healthcare has been suspended following serious non-compliance observed during the inspection of its health supplements and nutraceuticals manufacturing unit.”

The regulator has asked the company to immediately cease all food business activities until deficiencies are rectified and the same gets verified by the competent authority.

FSSAI pointed out that the manufacturing units got an overall compliance score of 12 per cent. The low score indicates “very serious failure and non-compliance of existing provisions”.

The regulator pointed out that manufacturing premises were extremely unhygienic and unorganised.

“Sediments of filth and sludge accumulated under the manufacturing tank, disorganised storage of raw materials and poor housekeeping created a serious risk of cross-contamination,” it added.

FSSAI also found major deficiencies in infrastructure and facilities.

These included inadequate storage arrangements, insufficient workspace, poor ventilation and lighting, damaged infrastructure, pest infestation and the absence of a valid drinking water test report.

“As the unit manufactures health supplements and nutraceuticals, a high-risk category of food consumed by children and other vulnerable groups, the unhygienic conditions and failure of food safety controls pose a serious and imminent threat to public health,” FSSAI said.

Spider webs, mould growth, flies, insects and exposed food waste were observed within the manufacturing area, the regulator added.

In the last few months, FSSAI has cracked down on many energy drink and alcoholic beverage companies for misleading claims and labelling. It has also issued notices to many e-commerce platforms.

These actions are based on consumer complaints, suo motu cognizance and also regular enforcement activities of food safety officers.

Related Posts

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry